lunes, 6 de noviembre de 2017

HSD3B1 Genotype and Outcomes With ADT After Radiotherapy for Localized Prostate Cancer - The ASCO Post

<em>HSD3B1</em> Genotype and Outcomes With ADT After Radiotherapy for Localized Prostate Cancer - The ASCO Post



HSD3B1 Genotype and Outcomes With ADT After Radiotherapy for Localized Prostate Cancer

Key Points

  • In patients receiving androgen-deprivation therapy for localized prostate cancer, the presence of the HSD3B1 (1245C) allele was associated with more rapid progression to metastasis after radiotherapy.
  • No effect of the allele was found for the time to disease progression or overall survival. 

No hay comentarios:

Publicar un comentario